The system earned FDA clearance in October and made its debut in April. The system is designed for SI joint fusion when treating sacroiliac joint disruptions, degenerative sacroiliitis and other conditions. It has a Transfixing-Cone, an ilium screw, a sacrum screw and associated instruments.
“The release of SiLO TFX is proceeding smoothly and rapidly as we deploy more instruments sets and implants into the field,” Petra Lopizzo, Aurora Spine’s director of operations, said in the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
